# GATA2

## Overview
GATA2 is a gene that encodes the GATA binding protein 2, a transcription factor belonging to the GATA family, which is characterized by its zinc finger domains. This protein plays a pivotal role in the regulation of hematopoiesis, the process of blood cell formation, by maintaining the proliferative state of hematopoietic progenitor and stem cells. GATA2 is involved in a complex network of interactions with other transcription factors and is subject to various post-translational modifications that modulate its activity. The gene's expression and function are critical for normal hematopoietic processes, and its dysregulation is associated with several hematological and immunological disorders, including MonoMAC syndrome and familial myelodysplastic syndrome. Mutations in GATA2 can lead to both germline and somatic alterations, contributing to a range of clinical manifestations and emphasizing the importance of genetic diagnosis and therapeutic interventions (Vicente2012The; Spinner2014GATA2; Fabozzi2022GATA).

## Structure
The GATA2 protein is a transcription factor characterized by two highly conserved zinc finger domains, known as ZF1 and ZF2, which are crucial for its DNA-binding capability and interaction with other proteins (Fabozzi2022GATA). These zinc fingers are of the Cys-X2-Cys-X17-Cys-X2-Cys type, with the N-terminal zinc finger (N-ZnF) contributing to DNA binding specificity and cofactor complex formation, while the C-terminal zinc finger (C-ZnF) is essential for recognizing the GATA consensus sequence (Vicente2012The).

GATA2 also contains two transactivation domains located in the N- and C-terminal regions, a nuclear localization signal, and a negative regulatory domain (Vicente2012The). The protein undergoes several post-translational modifications, including phosphorylation, acetylation, SUMOylation, and ubiquitination, which regulate its stability and transcriptional activity (Vicente2012The; Hayakawa2003Functional).

There are two main mRNA transcripts of GATA2, resulting in two protein isoforms: a larger form with 480 amino acids and a shorter form with 466 amino acids, the latter lacking part of the C-ZnF domain (Vicente2012The). These structural features and modifications are critical for GATA2's role in hematopoiesis and its interaction with other transcription factors.

## Function
GATA2 is a transcription factor essential for the regulation of hematopoiesis, the process of blood cell formation. It plays a critical role in maintaining the proliferative state of hematopoietic progenitor cells (HPCs) and hematopoietic stem cells (HSCs), ensuring their proper function and survival (Vicente2012The; Fabozzi2022GATA). GATA2 is highly expressed in quiescent HPCs and is induced early after growth factor stimulation, peaking before declining during advanced differentiation and maturation (Labbaye1995Differential). It is involved in a complex network of interactions with other transcription factors, such as RUNX1, SCL/TAL1, and PU.1, which are essential for hematopoiesis (Fabozzi2022GATA).

GATA2's activity is modulated by various post-translational modifications, including phosphorylation and acetylation, which affect its transcriptional activity and DNA-binding capabilities (Vicente2012The). It regulates the expression of genes involved in cell cycle regulation, megakaryopoiesis, and erythroid differentiation, influencing lineage decisions between erythroid and myeloid pathways (Vicente2012The). GATA2 is active in the nucleus, where it binds to specific DNA sequences to exert its regulatory functions (Vicente2012The). Its balanced expression is crucial for normal hematopoiesis, and dysregulation can lead to hematopoietic disorders (Vicente2012The).

## Clinical Significance
Mutations in the GATA2 gene are associated with a range of hematological and immunological disorders. GATA2 deficiency, caused by these mutations, leads to conditions such as MonoMAC syndrome, Emberger syndrome, and familial myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) (Hahn2011Heritable; Spinner2014GATA2). These conditions often present with immunodeficiency, characterized by severe monocytopenia, dendritic cell cytopenia, and B and NK lymphocytopenia, increasing susceptibility to infections by human papillomaviruses (HPV) and nontuberculous mycobacteria (NTM) (Largeaud2023Somatic; Spinner2014GATA2).

GATA2 mutations can be germline or somatic, with germline mutations often leading to myeloid malignancies and immunodeficiency (Largeaud2023Somatic; Sahoo2020Germline). Somatic mutations in GATA2 are linked to AML and other hematological phenotypes, sometimes involving gain-of-function characteristics (Zhang2008Gainoffunction). The clinical manifestations of GATA2 deficiency are diverse, including pulmonary disease, vascular/lymphatic dysfunction, and increased risk of thrombotic events and coagulopathy (Donadieu2018Natural; Spinner2014GATA2).

Alterations in GATA2 expression levels are also significant, with overexpression linked to poor prognosis in AML patients (Johnson2012Ciselement). The complexity of GATA2-related disorders underscores the importance of early genetic diagnosis and potential interventions like hematopoietic stem cell transplantation (HSCT) (Donadieu2018Natural; Spinner2014GATA2).

## Interactions
GATA2 is a transcription factor that engages in various protein-protein interactions, playing a crucial role in gene regulation. It interacts with the retinoic acid receptor alpha (RARα) in hematopoietic cells, forming complexes that allow retinoic acid to regulate transcription from GATA binding motifs. This interaction is independent of the retinoid X receptor (RXR), which typically partners with RARα (Tsuzuki2004Cross). GATA2's zinc finger domains are essential for these interactions, and specific mutations in these regions can disrupt the association with RARα (Tsuzuki2004Cross).

GATA2 also cooperates with the AP1 complex, including proteins such as Jun and Fos, to regulate the transcription of the endothelin-1 (ET-1) gene. This interaction is synergistic and involves direct protein-protein interactions, as demonstrated by immunoprecipitation experiments (Kawana1995Cooperative).

In the context of adipocyte differentiation, GATA2 interacts with the C/EBP family of transcription factors, particularly C/EBPα, to suppress differentiation. This interaction is mediated by the bZip region of C/EBPα and a specific region of GATA2, which is critical for its function in adipogenesis (Tong2005Interaction).


## References


[1. (Hahn2011Heritable) Christopher N Hahn, Chan-Eng Chong, Catherine L Carmichael, Ella J Wilkins, Peter J Brautigan, Xiao-Chun Li, Milena Babic, Ming Lin, Amandine Carmagnac, Young K Lee, Chung H Kok, Lucia Gagliardi, Kathryn L Friend, Paul G Ekert, Carolyn M Butcher, Anna L Brown, Ian D Lewis, L Bik To, Andrew E Timms, Jan Storek, Sarah Moore, Meryl Altree, Robert Escher, Peter G Bardy, Graeme K Suthers, Richard J D’Andrea, Marshall S Horwitz, and Hamish S Scott. Heritable gata2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nature Genetics, 43(10):1012–1017, September 2011. URL: http://dx.doi.org/10.1038/ng.913, doi:10.1038/ng.913. This article has 687 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng.913)

[2. (Vicente2012The) Carmen Vicente, Ana Conchillo, María A. García-Sánchez, and María D. Odero. The role of the gata2 transcription factor in normal and malignant hematopoiesis. Critical Reviews in Oncology/Hematology, 82(1):1–17, April 2012. URL: http://dx.doi.org/10.1016/j.critrevonc.2011.04.007, doi:10.1016/j.critrevonc.2011.04.007. This article has 184 citations.](https://doi.org/10.1016/j.critrevonc.2011.04.007)

[3. (Donadieu2018Natural) Jean Donadieu, Marie Lamant, Claire Fieschi, Flore Sicre de Fontbrune, Aurélie Caye, Marie Ouachee, Blandine Beaupain, Jacinta Bustamante, Hélène A. Poirel, Bertrand Isidor, Eric Van Den Neste, Antoine Neel, Stanislas Nimubona, Fabienne Toutain, Vincent Barlogis, Nicolas Schleinitz, Thierry Leblanc, Pierre Rohrlich, Felipe Suarez, Dana Ranta, Wadih Abou Chahla, Bénédicte Bruno, Louis Terriou, Sylvie Francois, Bruno Lioure, Guido Ahle, Françoise Bachelerie, Claude Preudhomme, Eric Delabesse, Hélène Cave, Christine Bellanné-Chantelot, and Marlène Pasquet. Natural history of gata2 deficiency in a survey of 79 french and belgian patients. Haematologica, 103(8):1278–1287, May 2018. URL: http://dx.doi.org/10.3324/haematol.2017.181909, doi:10.3324/haematol.2017.181909. This article has 133 citations.](https://doi.org/10.3324/haematol.2017.181909)

[4. (Kawana1995Cooperative) Masatoshi Kawana, Mu-En Lee, Elena E. Quertermous, and Thomas Quertermous. Cooperative interaction of gata-2 and ap1 regulates transcription of the endothelin-1 gene. Molecular and Cellular Biology, 15(8):4225–4231, August 1995. URL: http://dx.doi.org/10.1128/MCB.15.8.4225, doi:10.1128/mcb.15.8.4225. This article has 239 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.15.8.4225)

[5. (Tsuzuki2004Cross) Shinobu Tsuzuki, Kenji Kitajima, Toru Nakano, Annegret Glasow, Arthur Zelent, and Tariq Enver. Cross talk between retinoic acid signaling and transcription factor gata-2. Molecular and Cellular Biology, 24(15):6824–6836, August 2004. URL: http://dx.doi.org/10.1128/MCB.24.15.6824-6836.2004, doi:10.1128/mcb.24.15.6824-6836.2004. This article has 66 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.24.15.6824-6836.2004)

[6. (Sahoo2020Germline) Sushree S. Sahoo, Emilia J. Kozyra, and Marcin W. Wlodarski. Germline predisposition in myeloid neoplasms: unique genetic and clinical features of gata2 deficiency and samd9/samd9l syndromes. Best Practice &amp; Research Clinical Haematology, 33(3):101197, September 2020. URL: http://dx.doi.org/10.1016/j.beha.2020.101197, doi:10.1016/j.beha.2020.101197. This article has 76 citations.](https://doi.org/10.1016/j.beha.2020.101197)

[7. (Labbaye1995Differential) C Labbaye, M Valtieri, T Barberi, E Meccia, B Masella, E Pelosi, G L Condorelli, U Testa, and C Peschle. Differential expression and functional role of gata-2, nf-e2, and gata-1 in normal adult hematopoiesis. Journal of Clinical Investigation, 95(5):2346–2358, May 1995. URL: http://dx.doi.org/10.1172/jci117927, doi:10.1172/jci117927. This article has 100 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci117927)

[8. (Zhang2008Gainoffunction) Su-Jiang Zhang, Li-Yuan Ma, Qiu-Hua Huang, Guo Li, Bai-Wei Gu, Xiao-Dong Gao, Jing-Yi Shi, Yue-Ying Wang, Li Gao, Xun Cai, Rui-Bao Ren, Jiang Zhu, Zhu Chen, and Sai-Juan Chen. Gain-of-function mutation of gata-2 in acute myeloid transformation of chronic myeloid leukemia. Proceedings of the National Academy of Sciences, 105(6):2076–2081, February 2008. URL: http://dx.doi.org/10.1073/pnas.0711824105, doi:10.1073/pnas.0711824105. This article has 151 citations.](https://doi.org/10.1073/pnas.0711824105)

[9. (Johnson2012Ciselement) Kirby D. Johnson, Amy P. Hsu, Myung-Jeom Ryu, Jinyong Wang, Xin Gao, Meghan E. Boyer, Yangang Liu, Youngsook Lee, Katherine R. Calvo, Sunduz Keles, Jing Zhang, Steven M. Holland, and Emery H. Bresnick. Cis-element mutated in gata2-dependent immunodeficiency governs hematopoiesis and vascular integrity. Journal of Clinical Investigation, 122(10):3692–3704, October 2012. URL: http://dx.doi.org/10.1172/jci61623, doi:10.1172/jci61623. This article has 159 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci61623)

[10. (Hayakawa2003Functional) Fumihiko Hayakawa, Masayuki Towatari, Yukiyasu Ozawa, Akihiro Tomita, Martin L Privalsky, and Hidehiko Saito. Functional regulation of gata-2 by acetylation. Journal of Leukocyte Biology, 75(3):529–540, December 2003. URL: http://dx.doi.org/10.1189/jlb.0603389, doi:10.1189/jlb.0603389. This article has 50 citations and is from a peer-reviewed journal.](https://doi.org/10.1189/jlb.0603389)

[11. (Largeaud2023Somatic) Laetitia Largeaud, Matthew Collin, Nils Monselet, Francois Vergez, Vincent Fregona, Lise Larcher, Pierre Hirsch, Nicolas Duployez, Audrey Bidet, Isabelle Luquet, Jacinta Bustamante, Stephanie Dufrechou, Nais Prade, Marie Nolla, Camille Hamelle, Suzanne Tavitian, Christophe Habib, Mateo Meynier, Christine Bellanne-Chantelot, Jean Donadieu, Flore Sicre De Fontbrune, Claire Fieschi, Alina Ferster, Francois Delhommeau, Eric Delabesse, and Marlene Pasquet. Somatic genetic alterations predict hematological progression in gata2 deficiency. Haematologica, 108(6):1515–1529, February 2023. URL: http://dx.doi.org/10.3324/haematol.2022.282250, doi:10.3324/haematol.2022.282250. This article has 12 citations.](https://doi.org/10.3324/haematol.2022.282250)

[12. (Tong2005Interaction) Qiang Tong, Judy Tsai, Guo Tan, Gökhan Dalgin, and Gökhan S. Hotamisligil. Interaction between gata and the c/ebp family of transcription factors is critical in gata-mediated suppression of adipocyte differentiation. Molecular and Cellular Biology, 25(2):706–715, January 2005. URL: http://dx.doi.org/10.1128/MCB.25.2.706-715.2005, doi:10.1128/mcb.25.2.706-715.2005. This article has 294 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.25.2.706-715.2005)

[13. (Spinner2014GATA2) Michael A. Spinner, Lauren A. Sanchez, Amy P. Hsu, Pamela A. Shaw, Christa S. Zerbe, Katherine R. Calvo, Diane C. Arthur, Wenjuan Gu, Christine M. Gould, Carmen C. Brewer, Edward W. Cowen, Alexandra F. Freeman, Kenneth N. Olivier, Gulbu Uzel, Adrian M. Zelazny, Janine R. Daub, Christine D. Spalding, Reginald J. Claypool, Neelam K. Giri, Blanche P. Alter, Emily M. Mace, Jordan S. Orange, Jennifer Cuellar-Rodriguez, Dennis D. Hickstein, and Steven M. Holland. Gata2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood, 123(6):809–821, February 2014. URL: http://dx.doi.org/10.1182/blood-2013-07-515528, doi:10.1182/blood-2013-07-515528. This article has 575 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2013-07-515528)

[14. (Fabozzi2022GATA) Francesco Fabozzi, Angela Mastronuzzi, Giulia Ceglie, Riccardo Masetti, and Davide Leardini. Gata 2 deficiency: focus on immune system impairment. Frontiers in Immunology, June 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.865773, doi:10.3389/fimmu.2022.865773. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.865773)